FDA.reportPublic FDA data

1 ML nedosiran 160 MG/ML Prefilled Syringe

RxCUI
2675317
RxNorm name
1 ML nedosiran 160 MG/ML Prefilled Syringe
Display name
1 ML nedosiran 160 MG/ML Prefilled Syringe
Full name
1 ML nedosiran 160 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RIVFLOZANEDOSIRANNovo Nordiskace9d4bc-4d20-4beb-9e9d-8886904248332025-03-03Adverse reactionsExact identifier
rxcui: 2675317

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ace9d4bc-4d20-4beb-9e9d-888690424833nedosiran 160 MG in 1 ML Prefilled Syringe [PSN] · 1 ML nedosiran 160 MG/ML Prefilled Syringe [SCD] · nedosiran 160 MG (as nedosiran sodium 170 MG) per 1 ML Prefilled Syringe [SY]34These highlights do not include all the information needed to use RIVFLOZA safely and effectively. See full prescribing information for RIVFLOZA. RIVFLOZA ® (nedosiran) injection, for subcutaneous use Initial U.S. Approval: 202320250303